Aims: We developed an international registry to examine cardiovascular complications of
COVID-19. Methods: A REDCap form was created in March 2020 at Mayo Clinic in …

Background Since December 2019, an emerging outbreak of novel coronavirus disease
2019 (COVID-19) is caused by the severe acute respiratory syndrome–coronavirus-2 (SARS …

The Coronavirus 2019 (COVID-19) pandemic, caused by the Severe Acute Respiratory
Syndrome Coronavirus-2 (SARS-CoV-2) virus, has resulted in unprecedented morbidity and …

Background: Cardiovascular complications of coronavirus disease 2019 (COVID-19) are
critical for prognosis but have not been elucidated in Japan. Methods and Results: The …

In December 2019, a series of patients presented with a pneumonia of unknown origin in
Wuhan, China. A novel RNA betacoronavirus was identified as the liable pathogen of a …

Background Among many complications of coronavirus disease 2019 (COVID-19) there is a
wide range of cardiovascular (CV) problems ranging from mild to severe ones. Even …

ABSTRACT Introduction: Coronavirus disease 2019 (COVID-19) cases are increasing
rapidly worldwide. Similar to Middle East respiratory syndrome where cardiovascular …

Background Patients with COVID-19 have an increased risk of cardiovascular adverse
events during the acute phase. However, the long-term cardiovascular outcomes are …

Background Cardiovascular disease (CVD) was in common in coronavirus disease 2019
(COVID-19) patients and associated with unfavorable outcomes. We aimed to compare the …

Some time has already passed since the COVID-19 pandemic began in 2019, but little is
known about the long-term effects of SARS-CoV-2 infection on heart and blood vessel …